Back to Search
Start Over
Supplementary Data from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Methods, Supplementary Results, Supplementary Tables S1-S11
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....130631a30eed0d3c7f2f65db7a13d540